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Abstract   
 The plasma membrane Ca2+-ATPase (PMCA) pumps play an 
important role in the maintenance of precise levels of intracellular Ca2+, 
quintessential for the optimal functioning and long term survival of neurons.  
In this paper, we review evidence showing alterations in the PMCAs in aging 
brain. Additionally, we provide evidence showing defects in these 
transporters in Parkinson’s disease (PD). PMCA activity and protein levels 
in brain synaptic plasma membranes (SPMs) decline progressively with 
increasing age.  The PMCAs undergo functional and structural changes when 
exposed to reactive oxygen species known to be generated in the aging brain 
and in neurodegenerative disorders such as PD.  The major changes in the 
PMCAs include rapid inactivation, formation of aggregates, internalization 
from the plasma membrane and fragmentation by proteases.  Reduction of 
PMCA levels as occurs in aging and under conditions of oxidative stress may 
play an important role in compromised neuronal function in the aging brain 
and in PD. Therapeutic strategies that protect the PMCAs and stabilize 
[Ca2+]i homeostasis have the potential of serving as novel interventions in 
preventing and/or slowing down the degeneration of neurons in various 
chronic neurodegenerative disorders. 
 




 Neurons rely on calcium (Ca2+ ) signaling to regulate a wide array of 
important cellular processes such as the release of neurotransmitters, signal 
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transduction, induction of gene expression, synaptic plasticity, and learning and 
memory formation  (Foster & Kumar, 2002) (Foster & Norris, 1997).  
Following the transduction of the Ca2+ signal, neurons need to return the 
intracellular calcium [Ca2+]i to baseline levels within milliseconds in order to 
prepare the cell for the next round of stimulation. Defects in the handling of 
Ca2+ and consequent overload is believed to result in cytotoxicity eventually 
leading to neuronal cell death (Miller, 1991). The various mechanisms for 
restoring baseline resting [Ca2+]i following neuronal excitation include 
sequestration into the endoplasmic reticulum and mitochondria, buffering by 
Ca2+ binding proteins, and extrusion across the plasma membrane by the 
Na+/Ca2+ exchangers (NCXs) and the plasma membrane Ca2+-ATPase pumps 
(PMCAs) (Blaustein, 1988; Carafoli, 1992).  The PMCA pumps are regulated 
by the Ca2+ sensor protein calmodulin (CaM), which induces conformational 
changes within the protein causing the C-terminal autoinhibitory domain to 
move away from the active site of the enzyme, thus relieving autoinhibition and 
resulting in several-fold activation  (Enyedi et al., 1989; James et al., 1988).  
The PMCAs represent the major high affinity transport system at the plasma 
membrane responsible for the fine tuning of resting free [Ca2+]i  and 
counteracting transient increases that occur during Ca2+ signaling (Strehler & 
Zacharias, 2001).  The PMCA proteins are coded by four different genes that 
produce four distinct isoforms termed PMCA 1, 2, 3 and 4.  Neurons express 
all four isoforms of the protein and have multiple splice variants formed by 
alternative splicing of mRNA, attesting to the very complex nature of Ca2+ 
dynamics in nerve cells. 
 
Dyshomeostasis of Calcium in the Aging Brain: Role of the Calcium 
Pumps 
 There is an extensive body of literature showing that defects in Ca2+ 
homeostasis underlie neuronal dysfunction. If left unchecked, elevated levels 
of [Ca2+]i lead to cytotoxicity and eventual cell death. Evidence from our 
laboratory and work of others has shown alterations in Ca2+ regulating 
systems in brain neurons with increasing age (reviewed in (Foster & Kumar, 
2002; Gibson & Peterson, 1987; Squier & Bigelow, 2000; Thibault, Gant, & 
Landfield, 2007; Wojda, Salinska, & Kuznicki, 2008; A.  Zaidi, 2010)).  
Aged neurons have elevated levels of voltage-gated Ca2+ channels, the major 
system involved in the influx of extracellular Ca2+. To make matters worse, 
aged neurons have decreased activity of the NCXs, the sarco-endoplasmic 
reticulum Ca2+-ATPases (SERCAs) (Gomez-Villafuertes, Mellstrom, & 
Naranjo, 2007; Martinez, Vitorica, & Satrustegui, 1988; Thibault, Hadley, & 
Landfield, 2001; Verkhratsky & Toescu, 1998)  (Michaelis, 1989; Michaelis 
et al., 1996; Michaelis, Foster, & Jayawickreme, 1992; Michaelis, Johe, & 
Kitos, 1984; Yao et al., 1996) and the PMCAs (A. Zaidi, Gao, Squier, & 
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Michaelis, 1998), (Lipman, Chrisp, Hazzard, & Bronson, 1996).    The 
resultant effect of age-associated changes in the proteins that regulate  Ca2+ 
is an elevation in [Ca2+]i which is consequently detrimental to the health of 
neurons.  
 Our laboratory has been interested in the PMCAs for the last 20 years 
(A. Zaidi et al., 2003; A. Zaidi, Fernandes, Bean, & Michaelis, 2009; A. 
Zaidi et al., 1998; A. Zaidi & Michaelis, 1999). We were the first to show a 
progressive and significant decline in the activity (~50%)  of the PMCAs  in 
SPMs isolated from rat brain at five different ages covering the life span of 
the animal (Lipman et al., 1996; A. Zaidi et al., 1998). Reduction in PMCA 
activity is associated with a statistically significant decrease in maximum 
velocity (Vmax) with no appreciable change in the affinity of the enzyme for 
Ca2+ (Kact) (A. Zaidi et al., 1998).  An approximately 20% reduction in 
PMCA protein is observed at 34 months, the highest age of rats we tested, 
compared to the 5 month young adults (A. Zaidi et al., 1998).  The 
disproportional loss of activity vs protein levels indicate modifications in the 
protein that cause inactivation without complete removal from the SPMs. A 
more recent study on lipid raft microdomains isolated from SPMs at different 
ages has shown similar results, i.e., a disproportional loss of PMCA activity 
vs its protein levels (Jiang et al., 2014). Age-related reduction in the PMCA 
in SPMs and lipid rafts may be attributed to multiple causes such as 
decreased synthesis, altered stability, abnormal trafficking/targeting to 
SPMs, structural alterations leading to enhanced removal from the synaptic 
terminals, or modifications leading to reduced immunoreactivity, although 
none of these possibilities have been experimentally confirmed and 
validated.  Lowered PMCA activity and protein levels in SPMs as observed 
with increasing age is likely to contribute to the disruption of Ca2+ 
homeostasis, a hallmark of aged neurons.   
 
Oxidative Stress and the PMCAs  
 Post-translational modification to proteins and lipid peroxidation are 
major contributors of neuronal dysfunction in normal aging and in the 
pathophysiology of several neurodegenerative disorders including 
Parkinson’s disease (PD).  Reactive oxygen species-mediated oxidative 
modification of proteins may involve altered conformation, misfolding, 
aggregation and oxidation of amino acid residues.  To determine the 
vulnerability of the PMCAs to oxidative stress and to identify the pattern of 
oxidative modification that may appear on the protein upon exposure to 
oxidants with physiological relevance, we performed a series of studies using 
a variety of experimental approaches (A. Zaidi et al., 2003; A. Zaidi et al., 
2009; A. Zaidi & Michaelis, 1999).  Exposure of synaptic membranes to 
oxidizing agents such as H2O2, peroxynitrite and peroxyl radical generating 
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agents for a brief period of time (10 min at 37°C) caused rapid inactivation 
of the PMCA (A. Zaidi & Michaelis, 1999).  Loss of activity was due to a 
significant reduction in Vmax with no change in the affinity for Ca2+ or Kact 
consistent with our observations in the aging brain (A. Zaidi et al., 1998). 
The major structural alteration was the formation of high molecular weight 
aggregates of PMCA which were reversed by the addition of a reducing 
agent (dithiothreitol) and chaotropic agent (urea). These data suggested the 
contribution of the oxidation of cysteine residues to form disulfide bonds and 
increased hydrophobic interactions between PMCA molecules, respectively 
(Souza dos Santos, Saraiva, Ferraz da Costa, Scofano, & de Carvalho-Alves, 
2007; A. Zaidi & Michaelis, 1999). 
 To determine whether the effects of oxidants on the PMCA are a 
direct oxidation of the protein or mediated indirectly via lipid peroxidation, 
we purified the PMCA protein from its membrane environment. Red blood 
cell membranes rich in one of the isoforms (PMCA 4) were utilized for these 
studies. The purified PMCA protein was reconstituted into mixed micelles 
made from the phospholipid phosphatidylcholine and exposed to increasing 
doses of H2O2 for 10 minutes at 37ºC (A. Zaidi et al., 2003).  As in the case 
of synaptic membranes, the PMCA in red blood cell membranes was rapidly 
inactivated and formed high molecular weight aggregates suggesting a direct 
effect of the oxidant on the protein.  
 In the next series of studies, we used primary neurons to assess the 
effects of oxidants on the PMCA (A. Zaidi et al., 2009). The logic was to 
investigate the effects of oxidative stress on the PMCAs in a system closer to 
the physiological one, with antioxidant defense mechanisms in place.  
Primary cultured neurons (cortical) were exposed to increasing 
concentrations of the superoxide free radical generating agent paraquat. 
(Smith & Heath, 1976).  A 24 hour exposure to paraquat (5 µM – 100 µM) 
resulted in significant changes in PMCA activity which exhibited a biphasic 
response (A. Zaidi et al., 2009).  While low concentrations of paraquat (5-25 
µM) activated PMCA basal activity by ~two-fold and abolished its 
sensitivity to CaM, higher concentrations (50-100 µM) inhibited both basal 
and CaM-stimulated PMCA activity.  Paraquat treatment also led to 
aggregate formation and calpain-mediated proteolysis of the PMCA protein 
(A. Zaidi et al., 2009).  Our results are consistent with several studies 
investigating the effects of excitotoxic agents and neurotoxins on the PMCAs 
present in neurons (Hajimohammadreza et al., 1997; Kip & Strehler, 2007; 
Pottorf et al., 2006; Wang, Roufogalis, & Villalobo, 1989; Wang, Villalobo, 
& Roufogalis, 1988; A. Zaidi et al., 2009), and in non-neuronal cells (Bruce 
& Elliott, 2007; Marian, Mukhopadhyay, Borchman, Tang, & Paterson, 
2008; Xiao et al.).   
European Scientific Journal June 2015 /SPECIAL/ edition Vol.2   ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
279 
 Increase in oxidative stress and elevations in [Ca2+]i have also been 
linked to the activation of caspases, enzymes that mediate apoptosis, a form 
of programmed cell death (Berridge, 1998).  The link between the PMCAs 
and apoptosis was established when PMCA 4b was shown to be degraded by 
caspase 3 (Paszty et al., 2005; Paszty et al., 2002; Schwab et al., 2002).  
Cleavage by caspase forms a 120 kDa truncated form of the PMCA minus its 
CaM-binding autoinhibitory domain. (James et al., 1989; Papp et al., 1989; 
Wang et al., 1988),   As expected this form is fully active even in the absence 
of CaM (Paszty et al., 2005; Paszty et al., 2002), a condition that would help 
the cell to  counteract the increased Ca2+ load and protect it against death 
(Schwab et al., 2002).  However, under severe and more chronic conditions, 
the PMCAs may be down-regulated further impairing Ca2+ homeostasis and 
promoting cell death.   
 
The PMCAs and Neurodegeneration 
 While the contribution of overall neuronal Ca2+ dysregulation in age-
associated neurodegenerative disorders has been experimentally validated 
(reviewed in (Bezprozvanny & Mattson, 2008; Green & LaFerla, 2008; 
Mattson, 2007; Wojda et al., 2008)), the specific contribution of the PMCAs 
is just beginning to be elucidated. Conceptually, there are two major ways by 
which the PMCAs may either contribute to the initiation and progression of 
neurodegenerative diseases or be impacted by these chronic conditions.  Any 
change in PMCA function is likely to disrupt neuronal Ca2+ homeostasis and 
elevate [Ca2+]i which may promote the generation of abnormal forms of 
peptides/proteins such as the amyloid beta peptide in Alzheimer’s disease 
and alpha synuclein in PD.  Conversely, events downstream from the 
accumulation of the pathological forms of these peptides/proteins may 
disrupt energy homeostasis, increase membrane excitability, promote the 
formation of free radicals, elevate membrane-associated oxidative stress, and 
activate proteolytic enzymes all of which may consequently have an 
inhibitory effect on PMCA function.  Convincing experimental support for 
either one or both of these possibilities is still lacking in the literature.  
 The PMCAs have been found to be significantly down-regulated in 
experimental models of global ischemia-reperfusion injury and seizures 
(Paszty et al., 2005).  In preliminary studies, we found that exposure to 
hypoxic conditions led to a significant decline in PMCA activity with no 
change in its protein levels (unpublished observations).  Evidence suggests 
that the suppression of PMCA activity is not simply due to the disruption of 
ion gradients and altered energy homeostasis due to lowered ATP levels, but 
rather due to a direct oxidative modification and degradation of the PMCA 
protein (Lehotsky et al., 2002).  The relationship between the PMCAs and 
Alzheimer’s disease, the most common neurodegenerative disorder, was first 
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demonstarted by functional inativation of the PMCA by the amyloid beta 
peptide (Mark, Hensley, Butterfield, & Mattson, 1995; Mark, Lovell, 
Markesbery, Uchida, & Mattson, 1997; Mattson, Mark, Furukawa, & Bruce, 
1997).  More recent studies have further validated the involvement of the 
PMCA in Alzheimer’s disease (Berrocal et al., 2009).  PMCA activity in 
human brain tissue from Alzheimer’s disease patients shows altered affinity 
to Ca2+ as compared to age-matched controls (Berrocal et al., 2009) 
suggesting structural/conformational changes in the Ca2+ binding sites in the 
protein.  More interestingly, addition of exogenous amyloid beta peptide to 
control brain simulated many of the effects observed in Alzheimer’s disease 
brain (Berrocal et al., 2009).   
 In our laboratory, we are studying the PMCAs in PD, the most 
common movement neurodegenerative disorder. In a cell model of PD, we 
exposed the dopaminergic cell line SH-SY5Y neuroblastoma cells to the 
Parkinsonian mimetics methyl phenyl pyridinium (Zaidi A, 2009) and 6-
hydroxydopamine (A. R. Zaidi, A; Clark, S; Elliot, K and Ramlow, P 2012).  
We observed a significant loss of activity and protein levels upon exposure 
to these neurotoxins. Preliminary studies on human brain tissue from PD 
patients are consistent with the cell model showing a very significant 
reduction in PMCA activity.  Overall, the findings presented here suggest 
that the loss of the PMCAs are a common theme across several 
neurodegenerative diseases.  Further studies are needed to elucidate the 
underlying mechanisms and determine whether the observed changes in the 
PMCA pumps are a cause or consequence of the disease.  Therapeutic 
approaches that can protect the PMCAs and stabilize [Ca2+]i homeostasis 
may be capable of slowing or even preventing neuronal degeneration. The 
PMCAs are therefore presenting themselves as novel drug targets for 
therapeutic interventions in various chronic degenerative disorders. 
  
Conclusion: 
 The plasma membrane Ca2+-ATPase (PMCA) pumps are critical to 
the maintenance of precise levels of intracellular Ca2+, quintessential to the 
functioning of nerve cells.  The PMCAs in the SPMs and lipid raft 
microdomains diminish progressively with increasing age.  PMCA loss also 
occurs in Alzheimer’s disease and Parkinson’s disease, the two most 
common neurodegenerative disorders. This may be due to elevated levels of 
oxidative stress present in brain neurons in these chronic disorders.  
Downregulation of the PMCAs may further elevate the levels of intracellular 
Ca2+ leading to Ca2+ overload, subsequent cytotoxicity and eventual cell 
death. Strategies that protect the PMCA from oxidative damage and/or 
elevate its expression in neurons represent novel future therapeutic 
interventions.    
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